Breaking News Instant updates and real-time market news.

GILD

Gilead

$83.04

1.06 (1.29%)

07:12
10/11/17
10/11
07:12
10/11/17
07:12

Gilead treatment of pediatric ulcerative colitis granted FDA orphan status

Gilead's filgotinib maleate was granted FDA orphan status as a treatment of pediatric ulcerative colitis, according to a post to the agency's website. Reference Link

  • 06

    Nov

  • 12

    Feb

GILD Gilead
$83.04

1.06 (1.29%)

10/05/17
10/05/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Gilead (GILD) initiated with a Perform at Oppenheimer. 2. Mammoth Energy (TUSK) initiated with a Hold at Jefferies. 3. Heska (HSKA) initiated with a Buy at Canaccord. 4. Angie's List (ANGI) reinitiated with an Outperform at Oppenheimer. 5. CoStar Group (CSGP) reinstated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/09/17
MAXM
10/09/17
NO CHANGE
Target $56
MAXM
Buy
Juno price target raised to $56 on higher JCAR017 price assumptions at Maxim
Maxim analyst Jason McCarthy has increased his assumptions for pricing of Juno Therapeutics' (JUNO) JCAR017 to $450K from $300K in the U.S. and to $375K from $200K in the EU, leading him to also raise his price target on the stock to $56 from $34. He believes CAR-T remains "a three horse race," adding that while Novartis (NVS) and Gilead's (GILD) Kite are ahead, "Juno is coming up from behind." McCarthy maintains his Buy rating on Juno shares.
10/09/17
LEER
10/09/17
NO CHANGE
LEER
Leerink not worried about JAK safety, AbbVie '494 profile so far 'ok'
Leerink analyst Geoffrey Porges notes that the delayed approval of Incyte (INCY)/Eli Lilly (LLY) baricitinib and the reported thromboembolic events in AbbVie's (ABBV) ABT494/upadacitinib trials have called into question the safety of oral Janus kinase, or JAK, inhibitors. The analyst says that his detailed review of the safety literature suggests that these medicines offer an acceptable risk/benefit profile for serious inflammatory diseases and do not confer a significant increase in cardiovascular risk or venous thromboembolic events. Further, Porges continues to believe AbbVie's upadacitinib and Gilead's (GILD) filgotinib will be approved for serious inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease, and will capture the majority share of his peak risk-adjusted $12B estimated JAK market.
10/11/17
LEHM
10/11/17
INITIATION
Target $90
LEHM
Overweight
Gilead reinstated with an Overweight at Barclays
Barclays analyst Geoff Meacham reinstated Gilead Sciences with an Overweight rating and $90 price target. The company will continue to attract investor attention as its expansion into oncology puts visibility into the resumption of growth, the analyst contends.

TODAY'S FREE FLY STORIES

TGT

Target

$62.92

1.16 (1.88%)

, GOOG

Alphabet

$988.20

3.75 (0.38%)

11:20
10/23/17
10/23
11:20
10/23/17
11:20
Hot Stocks
Target climbs as retailer gears up for crucial holiday season »

EXCLUSIVE BRANDS: After…

TGT

Target

$62.92

1.16 (1.88%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

WMT

Wal-Mart

$88.24

0.8 (0.91%)

AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 08

    Nov

  • 15

    Nov

  • 15

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

  • 18

    Mar

XLF

Financial Select Sector

$26.67

0.025 (0.09%)

11:20
10/23/17
10/23
11:20
10/23/17
11:20
Options
Notable option play in SPDR Financial ETF Monday morning »

Notable option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:20
10/23/17
10/23
11:20
10/23/17
11:20
General news
Treasury announced a $45 B 4-week bill auction for Tuesday »

Treasury announced a $45…

$NSD

NASDAQ Market Internals

11:17
10/23/17
10/23
11:17
10/23/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
10/23/17
10/23
11:16
10/23/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$146.80

-2.81 (-1.88%)

11:15
10/23/17
10/23
11:15
10/23/17
11:15
Options
Palo Alto Networks put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

11:15
10/23/17
10/23
11:15
10/23/17
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
10/23/17
10/23
11:15
10/23/17
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

SINA

Sina

$110.48

-1.12 (-1.00%)

11:14
10/23/17
10/23
11:14
10/23/17
11:14
Hot Stocks
Aristeia says Glass Lewis endorses nominees for Sina board »

Aristeia Capital, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

JNJ

Johnson & Johnson

$143.95

1.5514 (1.09%)

11:13
10/23/17
10/23
11:13
10/23/17
11:13
Conference/Events
Johnson & Johnson management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

SNY

Sanofi

$49.59

0.075 (0.15%)

, TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.07

-0.15 (-0.53%)

11:11
10/23/17
10/23
11:11
10/23/17
11:11
Conference/Events
Worldwide Business Research to hold a summit »

BioNetwork Partnering…

SNY

Sanofi

$49.59

0.075 (0.15%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.07

-0.15 (-0.53%)

UNH

UnitedHealth

$207.31

-0.18 (-0.09%)

NVS

Novartis

$86.54

0.8 (0.93%)

HZNP

Horizon Pharma

$14.09

-0.05 (-0.35%)

ABBV

AbbVie

$95.55

-0.55 (-0.57%)

BAYRY

Bayer

$34.80

-0.41 (-1.16%)

MRK

Merck

$64.37

0.49 (0.77%)

RDHL

RedHill Biopharma

$9.25

0.47 (5.35%)

NBRV

Nabriva Therapeutics

$6.33

-0.31 (-4.67%)

PFE

Pfizer

$36.68

0.26 (0.71%)

TEVA

Teva

$14.70

-0.2 (-1.34%)

GILD

Gilead

$81.21

-0.38 (-0.47%)

ALXN

Alexion

$139.02

-1.44 (-1.03%)

GSK

GlaxoSmithKline

$40.76

-0.085 (-0.21%)

REGN

Regeneron

$432.98

-7.96 (-1.81%)

CELG

Celgene

$121.33

-14.63 (-10.76%)

LLY

Eli Lilly

$87.85

0.62 (0.71%)

AMGN

Amgen

$182.96

-1.16 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 27

    Oct

  • 27

    Oct

  • 28

    Oct

  • 31

    Oct

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 08

    Nov

  • 09

    Nov

  • 13

    Nov

  • 16

    Nov

  • 16

    Nov

  • 30

    Nov

  • 30

    Nov

  • 02

    Dec

  • 04

    Dec

  • 02

    Feb

  • 03

    Feb

  • 12

    Feb

  • 30

    Apr

  • 17

    May

  • 28

    May

CUB

Cubic

$54.75

1.7 (3.20%)

11:10
10/23/17
10/23
11:10
10/23/17
11:10
Periodicals
MTA ready to roll out new payment system built by Cubic, NY Post reports »

The MTA is ready to roll…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:07
10/23/17
10/23
11:07
10/23/17
11:07
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

NTNX

Nutanix

$26.67

0.33 (1.25%)

11:05
10/23/17
10/23
11:05
10/23/17
11:05
Options
Nutanix call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:05
10/23/17
10/23
11:05
10/23/17
11:05
General news
Euro$ interest rate futures are relatively steady »

Euro$ interest rate…

OPGN

OpGen

$0.37

-0.0014 (-0.38%)

11:01
10/23/17
10/23
11:01
10/23/17
11:01
Hot Stocks
OpGen announces award of $860K CDC contract »

OpGen announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PETS

PetMed Express

$36.74

0.87 (2.43%)

11:00
10/23/17
10/23
11:00
10/23/17
11:00
Recommendations
PetMed Express analyst commentary  »

PetMed Express target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

EGO

Eldorado Gold

$1.79

-0.38 (-17.51%)

10:57
10/23/17
10/23
10:57
10/23/17
10:57
Downgrade
Eldorado Gold rating change  »

Eldorado Gold downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

TMUS

T-Mobile

$60.46

-1.05 (-1.71%)

, S

Sprint

$6.99

0.055 (0.79%)

10:55
10/23/17
10/23
10:55
10/23/17
10:55
Hot Stocks
T-Mobile adds 1.3M customers as Un-carrier remains mum on potential Sprint deal »

Shares of T-Mobile US…

TMUS

T-Mobile

$60.46

-1.05 (-1.71%)

S

Sprint

$6.99

0.055 (0.79%)

DTEGY

Deutsche Telekom

$18.06

-0.09 (-0.50%)

SFTBF

SoftBank

$88.50

1.25 (1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 01

    Nov

  • 07

    Nov

  • 07

    Nov

  • 16

    May

HAS

Hasbro

$98.19

1.52 (1.57%)

10:55
10/23/17
10/23
10:55
10/23/17
10:55
Options
Hasbro put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

NWBI

Northwest Bancshares

$17.66

0.08 (0.46%)

10:52
10/23/17
10/23
10:52
10/23/17
10:52
Earnings
Northwest Bancshares reports Q3 EPS 24c, consensus 22c »

Net interest income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FAT

Fat Brands

10:52
10/23/17
10/23
10:52
10/23/17
10:52
Syndicate
Fat Brands opens at $12.80, IPO priced at $12 per share »

TriPoint Global acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLX

Helix Energy

$6.85

-0.91 (-11.73%)

10:49
10/23/17
10/23
10:49
10/23/17
10:49
Hot Stocks
Helix Energy falls after saying strategic review concluded »

On Helix Energy's Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

DOVA

Dova Pharmaceuticals

$26.73

-0.4 (-1.47%)

10:46
10/23/17
10/23
10:46
10/23/17
10:46
Conference/Events
Dova Pharmaceuticals to hold a pharmaceutical update conference call »

Management, along with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
10/23/17
10/23
10:45
10/23/17
10:45
General news
Breaking General news story  »

4-Week Bill Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.